Dawei Huang

811 citations
32 papers · 609 indexed · h-index 14
Topics
MicroRNA in disease regulation (3 papers)Traditional Chinese Medicine Studies (3 papers)Cancer, Lipids, and Metabolism (3 papers)

In The Last Decade

Dawei Huang

31 papers receiving 601 citations

Peers

Dawei Huang
Comparison fields: 5 of 92
  • Molecular Biology 232
  • Surgery 99
  • Cancer Research 82
  • Neurology 81
  • Pharmacology 78
Replace Huifeng Hao with:
Huifeng Hao China
Kyeong-A Kim South Korea
Ye Li China
Heng Miao China
Mohamed K. El-Kherbetawy Egypt
Haitao Xiao China
Yasuo Wakabayashi Japan
Chia-Yao Shen Taiwan
Guodong He China
Dawei Huang relative to Huifeng Hao China Huifeng Hao's profile →
Citations per field
00.5×5.5×
Huifeng Hao · 1×
Citations per year

Countries citing papers authored by Dawei Huang

Since Specialization
Citations

This map shows the geographic impact of Dawei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Huang more than expected).

Fields of papers citing papers by Dawei Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Huang. The network helps show where Dawei Huang may publish in the future.

Co-authorship network of co-authors of Dawei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Huang. A scholar is included among the top collaborators of Dawei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Huang. Dawei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 22
4 13
5 22
6 3
7 5
8 7
9 13
10 17
11 16
12 50
13 25
14
Synthesis, Biological Evaluation and Molecular Modeling of Cyclic Tetrapeptide Based Inhibitors HDAC
5
15 73
16 4
17 28
18 28
19 46
20 7

About Dawei Huang

Dawei Huang is a scholar working on Complementary and alternative medicine, Cancer Research and Gastroenterology, having authored 32 papers that have together received 609 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Traditional Chinese Medicine Studies (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Gastroenterology (50 citations), Geriatrics and Gerontology (30 citations) and Complementary and alternative medicine (58 citations). Dawei Huang has collaborated with scholars based in China, Taiwan and United Kingdom. Frequent co-authors include Szu‐Chuan Shen, Shanming Ruan, Di Qu, Y. Martin Lo, Wen‐Chung Huang, James Swi‐Bea Wu, Kuo‐Chang Huang, Sheng‐Hong Tseng, Lu Yang and Chang‐Jiang Zou. Their work appears in journals such as Nature Communications, PLoS ONE and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026